IKS Health is a care-enablement platform that takes on the administrative, clinical, and financial chores that pull US doctors away from their patients - essentially, it runs the non-clinical side of a physician practice so clinicians can just be clinicians. Founded in 2006, the company spent nearly two decades building a human-led, tech-assisted operating model that has now evolved into an AI-native platform, completing its IPO in India in December 2024. Its recurring approach is to take accountability for outcomes rather than just processing tasks, getting paid as a percentage of its clients’ revenue so that its own success is tied directly to making those practices healthier and more profitable.
Business segments
A single integrated platform that delegates every chore across the patient journey - from scheduling to billing to clinical documentation - for over 600 US physician groups and health systems.
1. Care Enablement Platform: an operating system for physician enterprises
The platform absorbs the entire administrative and clinical-chore burden of a medical practice, using agentic AI and a global team of clinically trained staff to turn the data in electronic health records into actions, decisions, and revenue.
- Spans the full patient journey - the platform covers 16 core workflows across five stages: before the visit (scheduling, financial clearance), during the visit (clinical documentation, scribing), after the visit (coding, billing, payment posting), between visits (prescription renewals, referrals), and inside acute-care settings.
- Three solution pillars under one roof - Revenue Optimization maximizes collections and minimizes claim denials; Clinical Support streamlines documentation, coding, and transcription; and Value-Based Care helps practices succeed in outcome-based payment models by coordinating care and managing risk.
- AI that knows when to act and when to ask - the platform’s automation runs on a five-level scale from fully manual to fully autonomous, with the company tracking autonomy feature by feature based on whether the outcome is deterministic or not, and whether the task touches an outside entity that may not be technology-ready.
- A suite of proprietary engines - the platform includes Optimix for revenue-cycle orchestration, IKS EVE™ for autonomous patient access and scheduling, Q CODE for AI-driven coding, the Scribble Suite™ for ambient clinical documentation, AssuRx™ for prescription renewals, and Stacks™ for document management, all fed by a Unifying Data Platform that aggregates data from billing systems, EHRs, and clearinghouses.
- Glass-box AI as a trust layer - the company’s AI maps documentation to standardized medical ontologies, validates relationships against known medical knowledge, and flags ambiguity when confidence is low, routing the case to a human reviewer so that every prediction is transparent, explainable, and auditable.
Revenue model and commercial approach
IKS gets paid as a percentage of its clients’ revenue - not by the headcount or transaction - so when its AI and workflows make a task more efficient, the client saves money and IKS captures the efficiency in its own margins.
- Outcome-based pricing, not FTE-based - unlike traditional IT services or BPO firms that bill per person deployed, IKS links its revenue to demonstrable client outcomes, which is why it does not disclose conventional contract-value metrics like ACV or TCV.
- Two pools of economic value - the model gives IKS both a recurring revenue stream as a percentage of client revenue and a direct share in the EBITDA improvement its platform generates, with some deals structured under a Net Economic Value Added (NEVA) model where IKS earns a portion of the uplift it creates.
- Non-linear growth - revenue grows significantly faster than headcount because the platform automates more work over time; in the most recent quarter, revenue grew 5.2% sequentially while net headcount actually declined.
- Sticky by design - 90% of revenue comes from repeat customers, client retention exceeds 99%, and the top 10 clients have an average relationship of nearly six years, because the platform becomes deeply embedded in the practice’s daily operations.
Group structure and partners
The listed Indian parent sits atop a US operating subsidiary that runs the platform, with a series of acquisitions - AQuity, ThinkDTM, Arai Solutions, and the pending TruBridge deal - adding inpatient capabilities, AI talent, and a proprietary electronic health record for the rural hospital market.
- Parent and principal operating subsidiary - Inventurus Knowledge Solutions Ltd is listed on the BSE and NSE; its wholly owned US subsidiary, IKS Inc., incorporated in Delaware in 2006, is the entity that delivers the care-enablement platform to American healthcare providers.
- AQuity brought inpatient scale - the $200 million acquisition in FY25 added clinical documentation, coding, and medico-legal solutions for the inpatient market, along with 500-plus enterprise customers; the acquired operating model was subsequently transformed from a heavy US-based human-led model to a tech-led, offshore-enabled one, expanding margins.
- ThinkDTM and Arai deepen the AI stack - the acqui-hire of ThinkDTM in March 2026 brought in the team that built the MyCare Hub agentic-AI patient-engagement platform, while the May 2026 acquisition of Arai Solutions added proprietary neuro-symbolic models, knowledge graphs, and ontologies that reduce dependency on third-party AI infrastructure and accelerate the build of small language models.
- TruBridge adds a system of record for rural hospitals - the pending $565 million acquisition of NASDAQ-listed TruBridge would bring a proprietary EHR installed in 700 to 800 rural and community hospitals, covering over 15 million patients, creating a closed-loop combination of IKS’s System of Action with a System of Record and opening a $575 million-plus whitespace for the platform inside TruBridge’s client base.